Acting FDA commissioner calls for independent investigation into approval of Alzheimer's drug
Sarah Silbiger/Getty Images North America/Getty Images FDA Acting Commissioner Dr. Janet Woodcock requested an investigation by the US Department of Health and Human Services Office of Inspector General into the controversial approval of the Alzheimer's disease drug Aduhelm. By Jamie Gumbrecht, CNN US Food and Drug Administration Acting Commissioner Dr. Janet Woodcock on Friday requested an investigation by the US Department of Health and Human Services Office of Inspector General into the controversial approval of the Alzheimer’s disease drug Aduhelm. In a letter posted on Twitter, Woodcoc...